Stock Stories
COVAX to receive up to 40 million doses of COVID-19 vaccine from Pfizer and BioNTech
The Coronavirus vaccine developed by Pfizer Inc. and BioNTech SE will provide 40 million doses to the COVAX vaccine distribution program, aiming to take COVID-19 vaccines to the world’s poorest countries. In a joint statement, the two pharmaceutical firms announced that distribution would start in
